Back to Search

ANNE SAVARESE, M.D.

M.D.

Pediatric Anesthesiology Physician

NPI: 1639111602Individual

Specialties, Licenses & Credentials

Pediatric Anesthesiology PhysicianPrimary

Anesthesiology — Pediatric Anesthesiology

Code: 207LP3000X

D40262(MD)
Anesthesiology Physician

Anesthesiology

Code: 207L00000X

D40262(MD)
Pain Medicine (Anesthesiology) Physician

Anesthesiology — Pain Medicine

Code: 207LP2900X

D40262(MD)

Research & Publications (11)

Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial.
PMID 19039248·Oncology·2009
3-trial
The withdrawal from oncogenetic counselling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sample.
PMID 19025627·J Exp Clin Cancer Res·2008
8-other
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients.
PMID 18506140·Br J Cancer·2008
8-other
Oral ondansetron is highly active as rescue antiemetic treatment for moderately emetogenic chemotherapy: results of a randomized phase II study.
PMID 18478278·Support Care Cancer·2008
3-trial
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer.
PMID 18281662·J Clin Oncol·2008
3-trial
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial.
PMID 16882344·BMC Cancer·2006
3-trial
New drugs in the treatment of recurrent or metastatic cervical cancer.
PMID 14693346·Crit Rev Oncol Hematol·2003
6-review
Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy.
PMID 12610195·J Clin Oncol·2003
3-trial
Perspectives in the clinical management of BRCA mutations carriers.
PMID 12585651·J Exp Clin Cancer Res·2002
6-review
Sedation, risk, and safety: do we really have data at last?
PMID 11581458·Pediatrics·2001
8-other
Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor.
PMID 10656436·Clin Cancer Res·2000
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
110 S PACA ST, SUITE 300 6TH FL
BALTIMORE, MD 21201

Location

Practice Location

110 S PACA ST, BALTIMORE, MD
(410) 328-6720

Quick Facts

NPI
1639111602
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
3
Locations
1
Publications
11

Are you this provider?

Claim Your Profile